An Invitation: Tell Us About Yourself
Aug31

An Invitation: Tell Us About Yourself

This post is the 100th we've written for The Haystack. So in celebration, we thought we'd try something a little different. We're here because we dig the chemistry and the business behind the pharmaceutical and biotech industries. But we know very little about why you're here. And we'd like to be sure we're giving you what you are looking for. So we're asking for your help. It's a plea that bloggers we admire (Ed Yong and many more) have put out many times before. Tell us about you. Even (and especially) if you've never commented here before. Do you or have you ever worked for a pharma company or biotech? Do you have a scientific background? Maybe you're more of a writer, investor, or businessperson. Feel free to say as much or as little as you like. Tell us what you think of The Haystack. We've been blogging here for nearly 6 months, and that's a good point to reflect on what we're doing well and what we can do better. How did you find us, and if you're a regular reader, what made you decide to stick around? What kinds of posts do you enjoy? What would you like to see less of? Use the space in the comments to tell us what's on your mind- the questions I've written are only a guide. Or for those not prone to public comment, feel free to email us (Lisa or Carmen)...

Read More
Just A Quick Note
Apr22

Just A Quick Note

Posting might be irregular here for the next day or two, as Lisa and I are in the midst of C&E News's advisory board meeting. In the meantime, I'll leave you with a few links of interest. Derek Lowe discusses Two Bad Ideas for remedying the pharma employment situation via @EricMilgram on Twitter, Pfizer warns of 50 layoffs in Durham, North Carolina Silence Therapeutics extends by one year its deal with AstraZeneca to develop methods of delivering drugs based on RNA...

Read More